Tratamiento Dirigido en el Cáncer de Pulmón Microcítico: El Papel de los Marcadores

Previous Page

Next Page

Page Background

EZH2 inhibition can markedly improve 2L in

chemoresistant SCLC

LX102 chemoresistant

LU149 chemoresistant

Gardner et al., Cancer Cell 2017

EZH2 is amenable to targeted therapy